Amalgamated Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-49,965
| Closed | -$8.26M | – | 2203 |
|
|
2021
Q2 | $8.26M | Buy |
49,965
+38,294
| +328% | +$6.39M | 0.07% | 285 |
|
|
2021
Q1 | $1.79M | Sell |
11,671
-925
| -7% | -$126K | 0.07% | 281 |
|
|
2020
Q4 | $1.58M | Buy |
12,596
+38
| +0.3% | +$4.25K | 0.06% | 319 |
|
|
2020
Q3 | $1.27M | Sell |
12,558
-321
| -2% | -$32.7K | 0.06% | 349 |
|
|
2020
Q2 | $1.25M | Sell |
12,879
-4,105
| -24% | -$382K | 0.06% | 324 |
|
|
2020
Q1 | $1.41M | Sell |
16,984
-301
| -2% | -$29.4K | 0.03% | 489 |
|
|
2019
Q4 | $1.92M | Buy |
17,285
+1,559
| +10% | +$160K | 0.04% | 528 |
|
|
2019
Q3 | $1.56M | Buy |
15,726
+2,237
| +17% | +$222K | 0.03% | 560 |
|
|
2019
Q2 | $1.34M | Sell |
13,489
-156
| -1% | -$14.9K | 0.03% | 627 |
|
|
2019
Q1 | $1.5M | Buy |
13,645
+234
| +2% | +$24.5K | 0.04% | 537 |
|
|
2018
Q4 | $1.23M | Buy |
13,411
+5,121
| +62% | +$518K | 0.03% | 551 |
|
|
2018
Q3 | $913K | Sell |
8,290
-3,990
| -32% | -$415K | 0.02% | 729 |
|
|
2018
Q2 | $1.15M | Buy |
12,280
+5,660
| +85% | +$487K | 0.03% | 691 |
|
|
2018
Q1 | $549K | Sell |
6,620
-132
| -2% | -$11.7K | 0.01% | 915 |
|
|
2017
Q4 | $615K | Buy |
6,752
+531
| +9% | +$44.2K | 0.02% | 889 |
|
|
2017
Q3 | $474K | Buy |
6,221
+1,291
| +26% | +$97.6K | 0.01% | 971 |
|
|
2017
Q2 | $370K | Buy |
+4,930
| New | +$342K | 0.01% | 1081 |
|
Other funds holding PRAH
Amalgamated Bank's PRAH Position: Q3 2021 in Review
Amalgamated Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 49,965 shares — an estimated $8.26M sold.
Amalgamated Bank first reported a position in PRAH in Q2 2017 and held it in 17 quarters. The position peaked at $8.26M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Amalgamated Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Amalgamated Bank sold 49,965 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $8.26M.
- Amalgamated Bank first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 17 quarters.
- Amalgamated Bank's PRA Health Sciences, Inc. position peaked at $8.26M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Amalgamated Bank's 13F filing for Q3 2021, filed 29 Oct 2021.